Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 20/20 | 1.00 |
| ▸ | ADORA2B | P29275 | 7/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.80 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.80 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.80 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.80 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.80 |
| ▸ | HPGD | P15428 | 1/20 | 0.80 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.80 |
| ▸ | TSHR | P16473 | 1/20 | 0.80 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.80 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.80 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.80 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.80 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8111292 | 0.94 | ADORA3 (1.00) | ADORA3ADORA2BALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL1662148 | 0.91 | ADORA3 (1.00) | ADORA3ADORA2BALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL1666099 | 0.89 | ADORA3 (1.00) | ADORA3ADORA2BALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL29386608 | 0.89 | ADORA3 (1.00) | ADORA3ADORA2BALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL927261 | 0.89 | ADORA3 (1.00) | ADORA3ADORA2BALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL8106742 | 0.87 | ADORA3 (1.00) | ADORA3ADORA2BALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL1663767 | 0.87 | ADORA3 (1.00) | ADORA3ADORA2BALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL6379174 | 0.85 | ADORA3 (0.91) | ADORA3ADORA2BALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL15124821 | 0.85 | ADORA3 (0.81) | ADORA3ADORA2BALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL1663534 | 0.84 | ADORA3 (1.00) | ADORA3ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| US-11857600-B2 | GPCR heteromer inhibitors and uses thereof | GPCR THERAPEUTICS, INC. (KR) | 2024-01-02 | — | — | US | disclosed |
| EP-2311806-A2 | Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists | The United States of America, Represented by the Secretary, Department of Health and Human Services (US) | 2011-04-20 | — | — | EP | disclosed |
| US-6066642-A | FOR SELECTIVELY BLOCKING THE A3 ADENOSINE RECEPTOR OF A MAMMAL | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-05-23 | — | — | US | disclosed |